Physician profile
Niloufer Khan
NPI 1124381181
$14,493.82
in general payments reported to CMS, 2019-2025
7 companies · $2,422 in 2025
The $2,422 reported for 2025 was more than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $73.39 · 2023: $603 · 2024: $11K · 2025: $2,422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $1,479 · Food and Beverage: $760 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,000.00 |
| Travel and Lodging | $1,479.36 |
| Food and Beverage | $759.57 |
| Education | $181.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adc Therapeutics America, INC. | $11,034.40 | 2024 | |
| Abbvie INC. | $2,421.74 | 2025 | |
| Kyowa Kirin, INC. | $708.22 | 2023-2024 | Poteligeo |
| Ipsen Biopharmaceuticals, INC | $181.50 | 2024 | Tazverik |
| Pfizer INC. | $74.57 | 2024 | |
| Seagen INC. | $73.39 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niloufer Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.